The Gabriella Miller Kids First Data Resource Center, a collaborative effort supported by the National Institutes of Health (NIH) Common Fund, announced the launch of its new Data Resource Portal to help accelerate the discovery of precision-based treatments for pediatric disorders, thanks to a collaborative effort led by the Center for Data Driven Discovery in Biomedicine (D3b) at the Children’s Hospital of Philadelphia (CHOP).

The Kids First Data Resource Portal provides access to newly released, large-scale NIH-sponsored and consortia-based pediatric genomic and clinical disease data, which enable collaborative cloud-based analyses across institutions around the globe, all within a security-compliant environment. Data from about 8,000 DNA and RNA samples from children affected with cancer or structural birth defects and their families will be ready for analysis.

“This portal fills a crucial need, providing researchers with easy access to genomic, clinical and phenotypic data from a variety of childhood cancers and structural birth defects that would be extremely difficult to find elsewhere,” noted James Coulombe, PhD, of the Developmental Biology and Structural Variation Branch at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human -Development.

'Discovery Milestone'

Adam Resnick, PhD

“The DRC’s Kids First research portal represents a data-driven discovery milestone for the implementation of tools and resources for performing biomedical research and for doing science collaboratively in entirely new and unprecedented ways in the hopes of accelerating discovery and clinical translation for each and every child suffering from cancer or a structural birth defect around the globe,” said Adam Resnick, PhD, lead principal investigator of the Kids First Data Resource Center and Director of the D3b at the Children’s Hospital of Philadelphia’s Division of -Neurosurgery.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.